
The NHS does not need more AI. It needs AI it can trust.
Ric Thompson of OneAdvanced explains why trusted, sovereign, domain-specific AI could help the NHS improve care navigation, productivity and patient outcomes safely at scale.

Ric Thompson of OneAdvanced explains why trusted, sovereign, domain-specific AI could help the NHS improve care navigation, productivity and patient outcomes safely at scale.

Dr. Marta Zanchi examines how Claude Science could reshape biotech AI, shifting defensibility towards orchestration, proprietary assets and healthcare’s complex last mile for investors.

Dr Alexander Jarasch of Neo4j explains how graph intelligence can connect fragmented biomedical data to accelerate rare disease diagnosis, drug repurposing, and treatment discovery.

Jon Robson, CEO of Mamedica, explains why improving patient access is essential to faster, more inclusive and effective clinical research across the UK.

Nicholas Batten of Nuumad explores how smarter pharmacy system design can help scale NHS care safely, balancing AI, deterministic logic and compliance.

Dr Marta G. Zanchi of Nina Capital explores why healthcare AI must balance automation with human oversight, trust, empathy and clinical accountability.

Connected wearables could make cardiovascular prevention continuous, equitable and scalable, helping people detect hypertension earlier and manage long-term heart health more effectively.

AI adoption in UK healthcare is accelerating, but limited traceability risks patient safety, accountability, and trust, highlighting the urgent need for transparent, auditable AI systems.

Valneva CEO Thomas Lingelbach on a striking new vaccine for Lyme Disease, and fighting vector-born disease in the era of climate change.

Despite bold digital ambitions, healthcare risks stalling in automation purgatory. Closing integration and skills gaps is key to turning digital potential into everyday clinical practice.

How tech-driven philanthropy can move faster, save lives and act as a real safety net, using Helpster Charity’s real-time, transparent healthcare funding model.

Thermo Fisher Scientific’s Santhosh Nair explains how advanced in-vitro diagnostics are transforming allergy care across Europe, enabling faster, more precise testing and improving outcomes for millions.

How workflow intelligence, powered by large language models, is ushering in a new era of efficiency and collaboration in diagnostic medicine.

Stanley Olisa, PR Manager at Helpster Charity, explores how companies can replace one-off CSR campaigns with transparent, tech-driven systems that deliver measurable, sustainable social impact.

Over two billion people suffer allergies. Many without knowing the cause. Here’s how Thermo Fisher Scientific unlocks the answers.

Ric Thompson of OneAdvanced explores how responsible AI, clinician co-design, and transparent innovation can help rebuild public trust and relieve pressure across the NHS.

Helpster Charity proves health insurance can work without premiums, offering fast, transparent, tech-driven cover that saves lives and protects families from poverty in Africa and Asia.

Dr Mark Palmer of Ansys explores how digital heart twins, AI, and in silico medicine are transforming cardiology, improving treatment planning, accelerating trials, and redefining patient care.

The UK public sector is rapidly adopting AI, but without ethical literacy and regulation, risks of bias and eroded trust loom. Skills and ethics must lead adoption.

Half the world lacks essential healthcare. Discover how tech solutions like Helpster’s digital-first model are transforming global health aid and closing life-threatening gaps in access.

Helpster’s Health Help Platform connects underserved patients in Africa and Asia with donors, hospitals, and volunteers, using technology to bridge healthcare gaps and deliver life-saving support.

Agentic automation is transforming UK healthcare by reducing admin, boosting efficiency and empowering staff—supporting a smarter, more responsive and digitally advanced NHS.

Helpster’s 2024 report reveals how tech-driven healthcare funding is saving lives in underserved regions, proving that innovation and transparency can transform global health outcomes.

Researchers at the University of Plymouth have shown that developing tech with – not for – the digitally excluded can produce remarkable results.

JPMorgan Chase & Co’s Tech For Social Good team is celebrating 10 years of doing good, impacting thousands of non-profits and empowering its own workforce.

Researchers at the University of Plymouth have shown that developing tech with – not for – the digitally excluded can produce remarkable results.

Developed in collaboration with AWS, Cancer Research UK’s new cloud-based platform is having a game-changing effect on matching patients to the most effective potential treatments.

Beam’s Alex Stephany and Julian Keenaghan tell us how the charity’s crowdfunding approach is grounded in tech

Sascha Giese of SolarWinds explores how ethical, inclusive AI can transform UK education by supporting teachers, enhancing accessibility, and ensuring equal learning opportunities.

Businesses must rethink recycling as a lifecycle strategy, using technology and circular practices to tackle resource pressures, reduce waste and unlock long-term sustainability opportunities.

At only 17, Emma Yang is the founder of Timeless, a mobile app that helps Alzheimer’s patients stay connected to their loved ones. In this podcast, Emma talks about the process of building her app and what it means to be named as one of the 100 Faces of Impact globally.

Leanne Kemp is founder of Everledger and a global authority on blockchain. In this podcast, Leanne discusses how the technology could create a new paradigm around “tech for good”.

Ric Thompson of OneAdvanced explains why trusted, sovereign, domain-specific AI could help the NHS improve care navigation, productivity and patient outcomes safely at scale.

Dr. Marta Zanchi examines how Claude Science could reshape biotech AI, shifting defensibility towards orchestration, proprietary assets and healthcare’s complex last mile for investors.

Dr Alexander Jarasch of Neo4j explains how graph intelligence can connect fragmented biomedical data to accelerate rare disease diagnosis, drug repurposing, and treatment discovery.

Jon Robson, CEO of Mamedica, explains why improving patient access is essential to faster, more inclusive and effective clinical research across the UK.

Nicholas Batten of Nuumad explores how smarter pharmacy system design can help scale NHS care safely, balancing AI, deterministic logic and compliance.

Dr Marta G. Zanchi of Nina Capital explores why healthcare AI must balance automation with human oversight, trust, empathy and clinical accountability.

Connected wearables could make cardiovascular prevention continuous, equitable and scalable, helping people detect hypertension earlier and manage long-term heart health more effectively.

AI adoption in UK healthcare is accelerating, but limited traceability risks patient safety, accountability, and trust, highlighting the urgent need for transparent, auditable AI systems.

Valneva CEO Thomas Lingelbach on a striking new vaccine for Lyme Disease, and fighting vector-born disease in the era of climate change.

Despite bold digital ambitions, healthcare risks stalling in automation purgatory. Closing integration and skills gaps is key to turning digital potential into everyday clinical practice.

How tech-driven philanthropy can move faster, save lives and act as a real safety net, using Helpster Charity’s real-time, transparent healthcare funding model.

Thermo Fisher Scientific’s Santhosh Nair explains how advanced in-vitro diagnostics are transforming allergy care across Europe, enabling faster, more precise testing and improving outcomes for millions.

How workflow intelligence, powered by large language models, is ushering in a new era of efficiency and collaboration in diagnostic medicine.

Stanley Olisa, PR Manager at Helpster Charity, explores how companies can replace one-off CSR campaigns with transparent, tech-driven systems that deliver measurable, sustainable social impact.

Over two billion people suffer allergies. Many without knowing the cause. Here’s how Thermo Fisher Scientific unlocks the answers.

Ric Thompson of OneAdvanced explores how responsible AI, clinician co-design, and transparent innovation can help rebuild public trust and relieve pressure across the NHS.

Helpster Charity proves health insurance can work without premiums, offering fast, transparent, tech-driven cover that saves lives and protects families from poverty in Africa and Asia.

Dr Mark Palmer of Ansys explores how digital heart twins, AI, and in silico medicine are transforming cardiology, improving treatment planning, accelerating trials, and redefining patient care.

The UK public sector is rapidly adopting AI, but without ethical literacy and regulation, risks of bias and eroded trust loom. Skills and ethics must lead adoption.

Half the world lacks essential healthcare. Discover how tech solutions like Helpster’s digital-first model are transforming global health aid and closing life-threatening gaps in access.

Helpster’s Health Help Platform connects underserved patients in Africa and Asia with donors, hospitals, and volunteers, using technology to bridge healthcare gaps and deliver life-saving support.

Agentic automation is transforming UK healthcare by reducing admin, boosting efficiency and empowering staff—supporting a smarter, more responsive and digitally advanced NHS.

Helpster’s 2024 report reveals how tech-driven healthcare funding is saving lives in underserved regions, proving that innovation and transparency can transform global health outcomes.

Researchers at the University of Plymouth have shown that developing tech with – not for – the digitally excluded can produce remarkable results.